Qing‐Sheng Mi
- Cancer Research top 1%
- MicroRNA in disease regulation 30
- Immunology top 1%
- Immune Cell Function and Interaction 32
- T-cell and B-cell Immunology 22
- Immunotherapy and Immune Responses 18
- Nephrology top 1%
- Gout, Hyperuricemia, Uric Acid 10
- Dermatology top 1%
- Developmental Neuroscience top 5%
-
- Diabetes and associated disorders 10
-
- Circular RNAs in diseases 10
- Extracellular vesicles in disease 9
- Co-authors
- Li ZhouZheng DongTerry L. DelovitchKirti BhattQingqing WeiShuang HuangMatthew WeilandAimin Jiang
- Cited by
- Cancer ResearchImmunologyNephrology
- Partner nations
- United StatesChinaCanada
In The Last Decade
Qing‐Sheng Mi
122 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Cancer Research 1.6k
- Immunology 1.8k
- Nephrology 564
- Dermatology 442
- Developmental Neuroscience 172
Countries citing papers authored by Qing‐Sheng Mi
This map shows the geographic impact of Qing‐Sheng Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing‐Sheng Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing‐Sheng Mi more than expected).
Fields of papers citing papers by Qing‐Sheng Mi
This network shows the impact of papers produced by Qing‐Sheng Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing‐Sheng Mi. The network helps show where Qing‐Sheng Mi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qing‐Sheng Mi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 18 | |
| 9 | 2021 | 18 | |
| 10 | 2021 | 33 | |
| 11 | 2021 | 17 | |
| 12 | 2016 | 65 | |
| 13 | 2015 | 68 | |
| 14 | 2012 | 1 | |
| 15 | 2012 | 29 | |
| 16 | 2011 | 26 | |
| 17 | 2010 | 403 | |
| 18 | 2007 | 2 | |
| 19 | 2006 | 80 | |
| 20 | 2002 | 6 |
About Qing‐Sheng Mi
Qing‐Sheng Mi is a scholar working on Immunology, Cancer Research and Dermatology, having authored 126 papers that have together received 5.8k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (32 papers), MicroRNA in disease regulation (30 papers), T-cell and B-cell Immunology (22 papers), Immunotherapy and Immune Responses (18 papers), Diabetes and associated disorders (10 papers), Gout, Hyperuricemia, Uric Acid (10 papers), Circular RNAs in diseases (10 papers) and Extracellular vesicles in disease (9 papers). The work is most often cited by research in Cancer Research (1.6k citations), Immunology (1.8k citations) and Nephrology (564 citations). Qing‐Sheng Mi has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Li Zhou, Zheng Dong, Terry L. Delovitch, Kirti Bhatt, Qingqing Wei, Shuang Huang, Matthew Weiland, Aimin Jiang, Peter Zucker and Chunmei Fu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.